Paraneoplastic syndrome: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
|||
| Line 15: | Line 15: | ||
}} | }} | ||
{{Paraneoplastic syndrome}} | {{Paraneoplastic syndrome}} | ||
{{CMG}} | {{CMG}} | ||
==[[Paraneoplastic syndrome overview|Overview]]== | ==[[Paraneoplastic syndrome overview|Overview]]== | ||
Revision as of 14:53, 14 August 2015
| Paraneoplastic syndrome | |
| DiseasesDB | 2064 |
|---|---|
| MeSH | D010257 |
|
Paraneoplastic syndrome Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Paraneoplastic syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Dietary Management | Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Organizations
The International Paraneoplastic Association (IPA) is an organization dedicated to providing support and information to those affected by paraneoplastic neurological disorders.
de:Paraneoplastisches Syndrom Template:WH Template:WikiDoc Sources